Thinking of conducting clinical trials in Asia?
Certainly more and more pharmaceutical companies are, and with good reason. The predominantly secondary healthcare environment, treatment-naïve patients and large population can mean less time to recruit and faster clinical development. Data quality is high, there are fewer competing studies, and the presence of large hospitals means more patients per site and dramatically reduced trial costs. But jumping on the Asian bandwagon without the proper forethought and knowledge could turn your trial into a tribulation.
Asian Clinical Trials: What to Know Before You Go was presented by Anthony Bishop, Quintiles East Asia and aired on 2004-07-27. For more details or to download this event, please visit our site at www.fxconferences.com
Over 50,000 attendees across hundreds of companies have taken advantage of our easy-to-use audio conferences to stay abreast of a fast-changing business environment. We specialize in Life Science conferences, along with topics relevant for HR, Marketing, Legal, and Finance professionals. Come check out our library of past audio conferences and see what's upcoming at FXConferences
Showing posts with label Anthony Bishop. Show all posts
Showing posts with label Anthony Bishop. Show all posts
Friday, December 25, 2009
Wednesday, July 16, 2008
Asian Clinical Trials: What to Know Before You Go
Thinking of conducting clinical trials in Asia?
Certainly more and more pharmaceutical companies are, and with good reason. The predominantly secondary healthcare environment, treatment-naïve patients and large population can mean less time to recruit and faster clinical development. Data quality is high, there are fewer competing studies, and the presence of large hospitals means more patients per site and dramatically reduced trial costs. But jumping on the Asian bandwagon without the proper forethought and knowledge could turn your trial into a tribulation
This audio conference is presented by Anthony Bishop, Quintiles East Asia. For more details, please visit our site www.fxconferences.com
Certainly more and more pharmaceutical companies are, and with good reason. The predominantly secondary healthcare environment, treatment-naïve patients and large population can mean less time to recruit and faster clinical development. Data quality is high, there are fewer competing studies, and the presence of large hospitals means more patients per site and dramatically reduced trial costs. But jumping on the Asian bandwagon without the proper forethought and knowledge could turn your trial into a tribulation
This audio conference is presented by Anthony Bishop, Quintiles East Asia. For more details, please visit our site www.fxconferences.com
Subscribe to:
Posts (Atom)